Receptivity to new smokeless tobacco products among test market populations

描述(申请人提供)：在卷烟销量下降的背景下，无烟烟草在美国的营销和销售呈上升趋势。目前，美国四大卷烟制造商已经推出了仿照瑞典鼻烟的新的无痰、无烟烟草产品，专门针对吸烟者。对于这些新的、相对较低的亚硝胺、无烟烟草产品的适当公共卫生方法，存在相当大的争议。然而，这些产品的可获得性越来越强是一个事实，到目前为止，几乎没有关于这些产品使用情况的基于人口的数据。国家癌症研究所和国家药物滥用研究所发布了一项计划公告，寻求进行研究，以提高对潜在减少接触烟草产品的使用的了解，包括开发监测系统，并评估可能伴随其使用的行为变化，如双重使用香烟和无烟产品。这个应用程序就是针对这些目的的。此时，印第安纳波利斯和达拉斯/堡垒。沃斯是唯一两个主要品牌骆驼鼻烟和万宝路鼻烟都有供应的地区。通过有效的双框架抽样方法，这项研究将在这些测试市场对4540名成年人进行基于人群的电话调查，旨在提供消费者对新鼻烟产品接受度的证据，吸烟者和非吸烟者尝试该产品并拒绝或采用该产品的比率，以及经常使用对吸烟模式的可能影响。此外，该项目将有助于完善监测措施，并将为认识、试验和定期使用鼻烟以及对危害的看法建立基准，今后可在广告信息、营销战略和/或产品构成发生变化时与之进行比较。通过增加手机补充，它将增加对只使用手机的家庭如何可能对鼻塞使用估计产生偏差的知识，并建设将手机样本纳入人口调查的能力。最后，如果鼻塞的采用率高到需要继续研究，这个项目将提供一个受访者小组，可以随着时间的推移进行跟踪。 与公共健康相关：在美国向吸烟者销售低亚硝胺无烟烟草产品可能会削弱戒烟动机，并增加烟草成瘾和相关疾病的患病率。另一方面，它们可以减少香烟的消费，从而降低疾病风险。这项研究初步了解了两个城市的居民对这些产品的反应。

DESCRIPTION (provided by applicant): In the context of declining sales of cigarettes, the marketing and sale of smokeless tobacco is on the rise in the United States. Currently four major U.S. cigarette manufacturers have introduced new spitless, smokeless tobacco products modeled on Swedish snus and targeted specifically to cigarette smokers. There is considerable controversy about the appropriate public health approach to these new, relatively low nitrosamine, smokeless tobacco products. Nevertheless the growing availability of these products is a fact, and to date there is virtually no population-based data on the use of these products. The National Cancer Institute and the National Institute of Drug Abuse have issued a Program announcement seeking research to improve knowledge about the use of potential reduced exposure tobacco products, including developing surveillance systems and assessing behavior changes that may accompany their use such as dual use of cigarettes and smokeless products. This application is directed to those purposes. At this time, Indianapolis and Dallas/Ft. Worth are the only areas where the two major brands, Camel Snus and Marlboro Snus, are both available. By means of an efficient, dual-frame sampling approach, this study will carry out a population-based telephone survey of 4540 adults in those test markets designed to provide evidence of the nature of consumer receptivity to the new snus products, the rate at which smokers and nonsmokers are trying the product and either rejecting it or adopting it for regular use, and the likely impact of regular use on smoking patterns. In addition, the project will contribute to refinement of surveillance measures and will establish benchmarks for awareness, trial and regular use of snus as well as perceptions of harmfulness against which future comparisons can be made as advertising messages, marketing strategies and/or product constituents change. By including a cell phone supplement, it will increase knowledge of how omission of cell phone only households may bias estimates of snus use, and build capacity to integrate cell phone samples into population surveys. Finally, if the rate of snus adoption is high enough to warrant continued study, this project will provide a panel of respondents who can be followed over time. PUBLIC HEALTH RELEVANCE: Low nitrosamine smokeless tobacco products being marketed to cigarette smokers in the U.S. could potentially undermine motivation to quit smoking, and increase the prevalence of tobacco addiction and related disease. On the other hand, they could reduce cigarette consumption which would lower disease risk. This study provides an initial look at how the population of two cities is responding to the products.